Home Search
Economics - search results
If you're not happy with the results, please do another search
Federal agencies reduce carbon emissions with energy savings performance contracts
Leslie Nicholls from the U.S. Department of Energy, explains how federal agencies reduce carbon emissions with energy savings performance contracts.
COVID-19 vaccines & genetic modification
Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.
How the NHS can de-risk its modernisation to upgrade safely and efficiently
Steven Shepherd, Healthcare Director, SAS UK, explores how upgrades can be made in a way that is cost-efficient and where the NHS professionals asked to use those systems are comfortable with the upgrades.
US pushes for investigation into origins of COVID-19
President Biden asked US intelligence agencies to begin investigating the origins of COVID-19 yesterday (26 May) - the international WHO team were unable to access all available data in their March trip to Wuhan.
A biotech shield for cowpea against the major insect pests
Jose M. Barrero, Donald J. MacKenzie, Richard E. Goodman and T.J.V. Higgins provide an in-depth look at what we need to know about a biotech shield for cowpea against the major insect pests.
Decarbonising the UK’s heat infrastructure
Ben Lynch, Director of Anthesis Group, discusses the challenges of decarbonising the UK’s heat infrastructure.
Study says 66% of Indian public blame Muslim population for COVID
Researchers at Monash Business School surveyed the Indian public in Uttar Pradesh, finding that 66% blame the Muslim population for the spread of COVID.
Financing recovery and growth
Christian Keuschnigg, Professor of Economics at the University of St. Gallen, explains how credit reallocation of banks boosts innovation and growth by steering capital to more productive use.
Options for struggling businesses in the aftermath of COVID-19
John Bell, director and founder of Clarke Bell, ponders the impact of COVID-19 on the economy and what options struggling businesses could be facing in the coming months and years ahead.
Turning the national illness service into the national health service
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
Pan African Food Security and Food Safety Issues
Food Insecurity is a major issue in the recent pandemic for people in countries throughout Africa and most of the world.
Prioritising maternal and child health in the COVID-19 era
Mahesh Karra, Assistant Professor of Global Development Policy, discusses the importance of maternal and child health during the COVID pandemic.
Deploying hydrogen transport infrastructure
Mark Griffin, Hydrogen Market Development Manager for Clean Fuels, BOC, explains how to deploy hydrogen transport infrastructure to meet net-zero in this guide for councils.
Chris Jackson – Protium Green Solutions Ltd
Chris is the founder and CEO of Protium, and the Chairman of the UK Hydrogen & Fuel Cell Association
Chris originally began working on hydrogen through the World Bank, where his research helped secure the Bank’s first internal funding for Hydrogen & Fuel Cell research in over a decade. Subsequently...
Innovation in chronic disease prevention
Dr Eugene Durenard, CEO of Hyperbolic Holdings GmbH discusses promising emerging technologies in the field of early detection and prevention of major chronic diseases.
Social and behavioural sciences to overcome daunting challenges
From public health and job creation to environmental sustainability and safer communities, the social and behavioural sciences empower people everywhere to find solutions, Dr Arthur Lupia & Jason Stoughton from the U.S. National Science Foundation explain.
It’s not just funding that will help non-profits, it’s skills
Paul Struthers, Managing Director, Sage, UK and Ireland, highlights how funding has been a systemic problem the charity sector has faced, but to ensure its longevity, it needs financial tools, digital skills and talent.
Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three
The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.
The heart of a bio-circular economy: Date palm
Dr Zaid, Secretary-General of Khalifa International Award for Date Palm & Agricultural Innovation and Dr Sandra Piesik, Founder of 3 Ideas B.V., tells us how date palm is the secret ingredient for a bio-circular economy.
Environment & human health: Pesticide risks
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, discusses alternative solutions to address pesticide risks for the environment and human health. Her article starts with the concern around pesticides use.